// App-Quantinova.ai

e13508 : A RT-qPCR Diagnostic System to Monitor Toca 511, a Cancer-selective Gene Therapy for the Treatment of Patients with Recurrent High-grade Glioma.

Researchers

Presenter

  • Erik Sudin

Principal Investigators

  • Zuguang Wang

  • Aprilgate Wang

  • Sara Weitz

  • Harwinder Sidhu

  • Aileen Shields

  • Joseph Chen

  • Malcolm Shields

  • Derek Ostertag

  • Arejas James Uzgiris

Medical Centers

  • Siemens Healthcare Diagnostics, Berkeley, CA

  • Tocagen, Inc., San Diego, CA

Locations

  • United States

Companies

  • Tocagen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-Grade Gliomas

  • Solid malignancies

  • Gliomas

Biomarkers

  • N/A

Drug/Treatment

  • vocimagene amiretrorepvec + Toca FC

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved